SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate

Bulletin of the NYU Hospital for Joint Diseases

Volumn 69, Issue 2, 2011, Pages 185-187

  de Souza, Aieska ^a   Solomon, Gary E ^b   Strober, Bruce E ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; DOXYCYCLINE; FOLIC ACID; INFLIXIMAB; ISOTRETINOIN; METHOTREXATE;

ABSENCE OF SIDE EFFECTS; ACNE; ACNE VULGARIS; ADD ON THERAPY; ADULT; ANTIBIOTIC THERAPY; ARTHRITIS; BONE DEMINERALIZATION; CASE REPORT; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ENTHESOPATHY; ERYTHEMA; FLEXOR TENDON; HUMAN; JOINT STIFFNESS; LORDOSIS; LUMBAR SPINE; MALE; METACARPOPHALANGEAL JOINT; OSTEOPOROSIS; PAPULE; PUSTULE; RADIOGRAPHY; REVIEW; SAPHO SYNDROME; SCAR; SKIN FISTULA; SKIN HYPERTROPHY; SKIN NODULE; SUPPURATIVE HIDRADENITIS; TREATMENT DURATION;

ACQUIRED HYPEROSTOSIS SYNDROME; ANTIBODIES, MONOCLONAL; HIDRADENITIS SUPPURATIVA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960472045     PISSN: 19369719     EISSN: 19369727     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Beretta-Piccoli BC, Sauvain MJ, Gal I, et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature. Eur J Pediatr. 2000 Aug;159(8):594-601.
2. Earwaker JW, Cotten A. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol. 2003 Jun;32(6):311-27.
3. Steinhoff JP, Cilursu A, Falasca GF, et al. A study of musculoskeletal manifestations in 12 patients with SAPHO syndrome. J Clin Rheumatol. 2002 Feb;8(1):13-22.
4. Ozyemisci-Taskiran O, Bölükbasi N, Gögüs F. A hidradenitis suppurativa related SAPHO case associated with features resembling spondylarthropathy and proteinuria. Clin Rheumatol. 2007 May;26(5):789-91.
5. Legrand E, Audran M, Rousselet-Chapeau MC, et al. Iliac osteosarcoma in a patient with SAPHO syndrome. Rev Rheum Engl Ed. 1995 Feb;62(2):139-41.
6. Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, et al. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology. 2008 Aug;47(8):1160-7.
7. Moll C, Hernández MV, Cañete JD, et al. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature. Semin Arthritis Rheum. 2008 Apr;37(5):299-306.
8. Alexis AF, Strober BE. Off-label dermatologic uses of anti- TNF-a therapies. J Cutan Med Surg. 2005 Dec;9(6):296-302.
9. Olivieri I, Padula A, Palazzi C. Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs. 2006 Oct;15(10):1229-33.
10. Rashtak S, Pittelkow MR. Skin involvement in systemic autoimmune diseases. Curr Dir Autoimmun. 2008;10:344-58.
11. Colina M, Lo Monaco A, Trotta F. [S.A.P.H.O. syndrome: a still little known clinical syndrome]. Recenti Prog Med. 2004 Oct;95(10):491-6. [Italian]
12. Yabe H, Ohshima H, Takano Y, et al. Mucosal lesions may be a minor complication of SAPHO syndrome: a study of 11 Japanese patients with SAPHO syndrome. Rheumatol Int. 2010 Aug;30(10):1277-83; Epub 2009 Sep 23.
13. Queiro R, Moreno P, Sarasqueta C, et al. Synovitis-acnepustulosis- hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile. Clin Exp Rheumatol. 2008 Jan-Feb;26:125-8.
14. Assmann G, Wagner AD, Monika M, et al. Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome. Rheumatol Int. 2010 Aug;30(10):1273-6; Epub 2009 Sep 25.
15. Ferguson PJ, Lokuta MA, El-Shanti HI, et al. Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum. 2008 Oct;58(10):3264-9.
16. Dumolard A, Gaudin P, Juvin R, et al. SAPHO syndrome or psoriatic arthritis? A familial case study. Rheumatology. 1999 May;38(5):463-7.
17. Wagner AD, Andresen J, Jendro MC, et al. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum. 2002 Jul;46(7):1965-8.
18. Ben Abdelghani K, Dran DG, Gottenberg JE, et al. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol. 2010 Aug 1;37(8):1699-704; Epub 2010 May 15.